Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response.


Journal

Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500

Informations de publication

Date de publication:
01 01 2022
Historique:
received: 08 06 2021
revised: 19 08 2021
accepted: 19 08 2021
pubmed: 25 8 2021
medline: 8 4 2022
entrez: 24 8 2021
Statut: ppublish

Résumé

Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the gastrointestinal tract, with mutant succinate dehydrogenase ( We describe methods for establishing novel patient-derived Molecular and metabolic characterization of our patient-derived m We report the first methods to establish patient-derived m

Identifiants

pubmed: 34426440
pii: 1078-0432.CCR-21-2092
doi: 10.1158/1078-0432.CCR-21-2092
pmc: PMC8738129
mid: NIHMS1736610
doi:

Substances chimiques

Succinate Dehydrogenase EC 1.3.99.1
Proto-Oncogene Proteins c-kit EC 2.7.10.1
Receptor, Platelet-Derived Growth Factor alpha EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

187-200

Subventions

Organisme : NCI NIH HHS
ID : R01 CA234245
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA226803
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA188652
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA023100
Pays : United States
Organisme : FDA HHS
ID : R01 FD006334
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA215081
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

©2021 American Association for Cancer Research.

Références

Nat Cell Biol. 2015 Oct;17(10):1317-26
pubmed: 26302408
Curr Med Chem. 2009;16(2):245-57
pubmed: 19149575
PLoS One. 2015 Mar 17;10(3):e0120531
pubmed: 25781619
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cancer Metab. 2014 Dec 15;2:21
pubmed: 25671108
Cancer Res. 2007 Mar 15;67(6):2497-507
pubmed: 17363567
Nat Rev Cancer. 2012 Jan 12;12(2):104-20
pubmed: 22237395
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Eur J Hum Genet. 2008 Jan;16(1):79-88
pubmed: 17667967
Proc Natl Acad Sci U S A. 2003 May 27;100(11):6706-11
pubmed: 12754375
Cancer. 2005 Oct 15;104(8):1706-12
pubmed: 16134177
Lab Invest. 2002 May;82(5):663-5
pubmed: 12004007
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Cancer Cell. 2017 Dec 11;32(6):856-868.e5
pubmed: 29198914
Cell Rep. 2020 Mar 31;30(13):4551-4566.e7
pubmed: 32234487
Am J Med Genet. 2002 Mar 1;108(2):132-9
pubmed: 11857563
Cancer Cell. 2005 Jan;7(1):77-85
pubmed: 15652751
Cancer Cell. 2013 Jun 10;23(6):709-11
pubmed: 23763995
Oncogene. 2001 Aug 16;20(36):5054-8
pubmed: 11526490
Cancer Res. 2008 Jun 1;68(11):4058-67
pubmed: 18519664
Cancer. 2003 Dec 15;98(12):2693-9
pubmed: 14669291
Cancer Discov. 2013 Jun;3(6):648-57
pubmed: 23550148
Cell. 2020 Jan 9;180(1):188-204.e22
pubmed: 31883794
Mol Cell Biol. 2008 Jan;28(2):718-31
pubmed: 17967865
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
Nucleic Acids Res. 2012 Aug;40(15):e115
pubmed: 22730293
Int J Cancer. 2014 Dec 1;135(11):2711-20
pubmed: 24752622
Nucleic Acids Res. 2012 Jan;40(Database issue):D1144-9
pubmed: 22086960
Endocr Relat Cancer. 2018 Nov;25(11):943-954
pubmed: 29967109
Clin Cancer Res. 2019 Jan 15;25(2):609-618
pubmed: 30274985
J Biomed Res. 2010 Nov;24(6):424-35
pubmed: 23554659
J Clin Endocrinol Metab. 1997 Jun;82(6):1852-6
pubmed: 9177395
J Biomed Biotechnol. 2012;2012:987495
pubmed: 22701311
Genes Dev. 2012 Jun 15;26(12):1326-38
pubmed: 22677546
Mol Cancer Ther. 2012 Jun;11(6):1289-99
pubmed: 22532597
Transl Oncol. 2016 Dec;9(6):512-520
pubmed: 27816688
Oncotarget. 2015 Oct 20;6(32):32955-65
pubmed: 26460615
Nat Commun. 2015 Sep 03;6:8154
pubmed: 26333361
Clin Med Insights Oncol. 2018 Apr 09;12:1179554918763367
pubmed: 29720885
Horm Metab Res. 2009 Sep;41(9):703-6
pubmed: 19536732
Nat Commun. 2015 Nov 02;6:8784
pubmed: 26522426
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cell. 1977 Apr;10(4):697-702
pubmed: 558831
FASEB J. 2020 Jan;34(1):303-315
pubmed: 31914648
Oncotarget. 2017 Dec 12;9(3):3946-3955
pubmed: 29423096
Genes Dis. 2016 May 11;3(3):198-210
pubmed: 30258889
Nature. 2019 Nov;575(7781):229-233
pubmed: 31666694
Cell. 1980 Mar;19(3):607-16
pubmed: 6965887
Methods Mol Biol. 2019;1978:219-241
pubmed: 31119666
Mol Endocrinol. 2010 Dec;24(12):2382-91
pubmed: 20980436
Cancer Res. 2005 Sep 1;65(17):7573-9
pubmed: 16140920
Curr Protoc Toxicol. 2014 May 27;60:25.2.1-16
pubmed: 24865646
Cancer Metastasis Rev. 2019 Sep;38(3):525-535
pubmed: 31773431
Cancer Res. 2005 Aug 1;65(15):6631-9
pubmed: 16061643
Sci Rep. 2020 May 14;10(1):7996
pubmed: 32409663

Auteurs

Mayra Yebra (M)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego, California.

Shruti Bhargava (S)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego, California.

Avi Kumar (A)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Bioengineering, University of California San Diego, La Jolla, California.

Adam M Burgoyne (AM)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Medicine, Division of Hematology Oncology, University of California San Diego, San Diego, California.

Chih-Min Tang (CM)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego, California.

Hyunho Yoon (H)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego, California.

Sudeep Banerjee (S)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego, California.

Joseph Aguilera (J)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California.

Thekla Cordes (T)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Bioengineering, University of California San Diego, La Jolla, California.

Vipul Sheth (V)

Department of Radiology, Stanford University, Palo Alto, Stanford, California.

Sangkyu Noh (S)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego, California.

Rowan Ustoy (R)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego, California.

Sam Li (S)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego, California.

Sunil J Advani (SJ)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California.

Christopher L Corless (CL)

Department of Pathology, OHSU Knight Cancer Institute, Portland, Oregon.

Michael C Heinrich (MC)

Hematology/Medical Oncology, Portland VA Health Care System and OHSU Knight Cancer Institute, Portland, Oregon.

Razelle Kurzrock (R)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Medicine, Division of Hematology Oncology, University of California San Diego, San Diego, California.
Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, San Diego, California.

Scott M Lippman (SM)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Medicine, Division of Hematology Oncology, University of California San Diego, San Diego, California.
Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, San Diego, California.

Paul T Fanta (PT)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Medicine, Division of Hematology Oncology, University of California San Diego, San Diego, California.
Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, San Diego, California.

Olivier Harismendy (O)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Medicine, Division of Biomedical Informatics, University of California San Diego, San Diego, California.

Christian Metallo (C)

Moores Cancer Center, University of California San Diego, La Jolla, California.
Department of Bioengineering, University of California San Diego, La Jolla, California.
Diabetes and Endocrinology Research Center, University of California San Diego, La Jolla, California.
Institute of Engineering in Medicine, University of California San Diego, La Jolla, California.

Jason K Sicklick (JK)

Moores Cancer Center, University of California San Diego, La Jolla, California. jsicklick@health.ucsd.edu.
Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego, California.
Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, San Diego, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH